Scarica l'app Stockscreener
2.47
4.22%
0.10
Pre-mercato:
2.54
0.07
+2.83%
Precedente Chiudi:
$2.37
Aprire:
$2.37
Volume 24 ore:
1.53M
Relative Volume:
1.10
Capitalizzazione di mercato:
$474.46M
Reddito:
$199.19M
Utile/perdita netta:
$-16.02M
Rapporto P/E:
-29.16
EPS:
-0.0847
Flusso di cassa netto:
$168.00K
1 W Prestazione:
+14.88%
1M Prestazione:
-5.00%
6M Prestazione:
+97.60%
1 anno Prestazione:
+32.80%
Intervallo 1D:
$2.34
$2.50
Intervallo di 1 settimana:
$2.045
$2.50
Portata 52W:
$1.12
$2.955
Cerus Corp Stock (CERS) Company Profile
Nome
Cerus Corp
Settore
Industria
Telefono
(925) 288-6000
Indirizzo
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.47 | 455.25M | 199.19M | -16.02M | 168.00K | -0.0847 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-12 | Iniziato | Craig Hallum | Buy |
| 2023-01-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-17 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Iniziato | BTIG Research | Buy |
| 2019-11-13 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-08-28 | Iniziato | Stifel | Buy |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Ripresa | BTIG Research | Neutral |
| 2016-07-07 | Ripresa | Cantor Fitzgerald | Buy |
| 2015-12-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2014-05-02 | Reiterato | MLV & Co | Buy |
| 2013-04-24 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-15 | Reiterato | MLV & Co | Buy |
| 2012-04-17 | Iniziato | Cantor Fitzgerald | Buy |
| 2012-02-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Reiterato | MLV & Co | Buy |
| 2011-06-03 | Iniziato | Wedbush | Outperform |
| 2011-03-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Aggiornamento | Avondale | Mkt Perform → Mkt Outperform |
Mostra tutto
Cerus Corp Borsa (CERS) Ultime notizie
Cerus sets March 2 date for Q4 and full-year 2025 earnings call - Stock Titan
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026 - Yahoo Finance
Cerus (CERS) Projected to Post Quarterly Earnings on Thursday - Defense World
Will Cerus Corporation (CU2) stock announce special dividend2025 Key Lessons & Proven Capital Preservation Tips - mfd.ru
Market Wrap: Is VLGEAs ROE strong enoughQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Cerus (CERS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Cerus director Timothy L. Moore to step down after 2026 annual meeting - Investing.com
Cerus announces planned board transition as director departs - TipRanks
New German trial tests safer platelets for cancer patients - stocktitan.net
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Lowers Stock Holdings in Cerus Corporation $CERS - MarketBeat
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Cerus (NASDAQ:CERS) Sets New 52-Week HighWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA) - The Globe and Mail
TD Cowen reiterates Buy rating on Cerus stock after strong Q4 results - Investing.com
CERS Projects Revenue Growth in 2026 - GuruFocus
Cerus (CERS) Reports Significant Global Expansion of INTERCEPT B - GuruFocus
Cerus (CERS) Reports Strong Revenue Growth Driven by INTERCEPT F - GuruFocus
Cerus expects 14% jump in 2025 topline, guides 2026 (CERS:NASDAQ) - Seeking Alpha
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Yahoo Finance
Revenue Check: Why Cerus Corporation stock is recommended by analysts2025 Volume Leaders & Risk Controlled Daily Trade Plans - Улправда
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving Average – Should You Sell? - Defense World
2026 world cup canada semifinals top scorers low block match prediction analysisMarket Risk Summary & AI Driven Price Forecasts - ulpravda.ru
What hedge fund activity signals for CNVS stockWeekly Gains Report & Safe Entry Zone Identification - ulpravda.ru
What insider trading reveals about Cerus Corporation stockMarket Volume Report & Verified Chart Pattern Trade Signals - Улправда
2026 world cup team news tips: Why Cerus Corporation stock is recommended by analysts2026 world cup usa national team quarterfinals young talents set piece tactics knockout prediction guide - ulpravda.ru
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) - Finviz
Assenagon Asset Management S.A. Purchases 358,548 Shares of Cerus Corporation $CERS - Defense World
Analysts’ Top Healthcare Picks: Cerus (CERS), Entera Bio (ENTX) - The Globe and Mail
Financial Analysis: Cerus (NASDAQ:CERS) vs. PURE Bioscience (OTCMKTS:PURE) - Defense World
Cerus (CERS): Strong Growth Potential and Increased Valuation - GuruFocus
Can Cerus Corporation (CU2) stock test all time highs2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Улправда
Can Cerus Corporation stock resist market sell offsJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
Cerus announces group purchasing pact with Blood Centers of America - MSN
Will Cerus Corporation stock beat EPS estimatesJuly 2025 Technicals & Short-Term Swing Trade Alerts - Улправда
Why Cerus Corporation stock is recommended by analystsJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
Cerus Corporation (NASDAQ:CERS) Stock Catapults 33% Though Its Price And Business Still Lag The Industry - 富途牛牛
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Cerus Shares Surge on Strategic Deal and Financial Momentum - AD HOC NEWS
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Cerus Corporation CU2 Stock Analysis and ForecastEvening Star Patterns & Exceptional Capital Trading - earlytimes.in
Cerus signs purchasing agreement with Blood Centers of America By Investing.com - Investing.com Nigeria
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America - Bakersfield.com
Cerus signs purchasing agreement with Blood Centers of America - Investing.com
Cerus Corp Azioni (CERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):